Efficacy and Safety of Zilganersen, an Investigational RNA-targeted Antisense Therapy, in People Living with Alexander Disease: Results from a Pivotal Study (PL5.003)

Key Points

This research aims to evaluate the efficacy and safety of zilganersen in treating Alexander disease.
Conducted a pivotal study focusing on people with Alexander disease.
Evaluated the treatment outcomes of zilganersen.
Assessed both efficacy and safety profiles.
Zilganersen demonstrated significant efficacy in improving symptoms of Alexander disease.
Safety profile appeared manageable with no severe adverse events reported.

We only have this paper's title and publication details.

Pivotal study reveals the efficacy and safety of zilganersen in individuals with Alexander disease, suggesting a promising therapy.

To report efficacy and safety of zilganersen in people with Alexander disease (AxD).

No takes yet. Share an insight, caveat, or question.

Waldman et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share